% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • weightbayou weightbayou Jul 20, 2013 3:34 PM Flag

    8th World Congress of Melanoma July 17-20

    Combining the HSP90 inhibitor, AT13387, with vemurafenib delays the emergence of resistance in a preclinical model of BRAF V600E mutant melanoma.
    Smyth, T*, Lewis, J, Thompson, N, Lyons, J, Azab, M, Wallis, N
    Astex Pharmaceuticals, Cambridge, United Kingdom

    Sentiment: Strong Buy